Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ammirati F, Colivicchi F, Santini M et al. (2000) Diagnosing syncope in clinical practice. Eur Heart J 21: 935–940
Ammirati F, Colivicchi F, Santini M et al. (2001) Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104: 52–57
Baron-Esqivias G, Pedrote A, Cayuela A et al. (2002) Long-term outcome of patients with asystole induced by head-up tilt test. Eur Heart J 23: 483–489
Benditt DG (1997) Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. PACE 20: 572–584
Benditt DG, Fahy GJ, Lurie KG et al. (1999) Pharmacotherapy of neurally mediated syncope. Circulation 100: 1242–1248
Brignole M, Menozzi C, Moya A et al. (2001) Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104: 2045–2050
Brignole M, Croci F, Menozzi C et al. (2002) Isometric arm-counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40: 2053–2059
Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study (VPS) J Am Coll Cardiol 33: 16–20
Connolly SJ, Sheldon R, Thorpe KE et al. for the VPS II Investigators (2003) The Second Vasovagal Pacemaker Study (VPS II). JAMA 289: 2224–2229
Corrado D, Basso C, Thiene G et al. (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30: 1512–1520
Cox MM, Perlman BA, Mayor MR et al. (1995) Acute and long-term betaadrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 26: 1293–1298
Dendi R, Goldstein DS (2002) Meta-analysis of non-selective versus β-1-Adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. Am J Cardiol 89: 1319–1321
Delepine S, Prunier F, Leftheriotis G et al. (2002) Comparison between isoproterenol and nitroglycerin sensitized head-upright tilt in patients with unexplained syncope and negative or positive passive head-up tilt response. Am J Cardiol 90: 488–491
Di Girolamo E, Iorio Di C, Sabatini P et al. (1999) Effects of paroxetine hydrochloride on refractory vasovagal syncope: a randomized, doubleblind, placebo-controlled study. J Am Coll Cardiol 33: 1227–1230
Flevari P, Livanis EG, Theodorakis GN et al. (2002) Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients well-being. J Am Coll Cardiol 40: 499–504
Fujimura O, Yee R, Klein GJ et al. (1989) The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by bradycardia. N Engl J Med 321: 1703–1707
Goldstein DS, Holmes C, Frank SM et al. (2003) Sympathoadrenal imbalance before neurocardiogenic syncope. Am J Cardiol 91: 53–58
Iskos D, Shultz JJ, Benditt DG (1998) Recurrent supine syncope: an unusual manifestation of the neurally-mediated faint. J Cardiovasc Electrophysiol 9: 441–444
Kapoor WN (2002) Current evaluation and management of syncope. Circulation 106: 1606–1609
Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope. Ann Neurol 52: 342–345
Kenny RA, Ingram A, Bayliss J, Sutton R (1986) Head-up tilt: a useful test for investigating unexplained syncope. Lancet: 1352–1354
Kenny RA (2002) Neurally mediated syncope. Clin Geriatr Med 18: 191–210
Kluger J, Bazunga M, Goldman R et al. (1998) Usefulness of intravenous metoprolol to prevent syncope induced by head-up tilt. Am J Cardiol 82: 820–823
Krahn AD, Klein GJ, Fitzpatrick A et al. (2002) Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing Clin Electrophysiol 25: 37–41
Krahn AD, Klein GJ, Yee R, Skanes AC (2001) Randomized Assessment of Syncope Trial — Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104: 46–51
Krediet CTP, Dijk N van, Linzer M (2002) Management of vasovagal syncope. Circulation 106: 1684–1690
Lieshout JJ van, Wieling W, Karemaker JM (1997) Neural circulatory control in vasovagal syncope. PACE 20: 753–763
Linzer M, Yang EH, Estes M et al. (1997a) Diagnosing syncope: Part 1: Value of history, physical examination, and electrocardiography. Ann Intern Med 126: 989–996
Linzer M, Yang EH, Estes M et al. (1997b) Diagnosing syncope: Part 2: Unexplained syncope. Ann Intern Med 127: 76–86
Madrid A, Ortega I, Rebello GJ et al. (2001) Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in a highly symptomatic population. J Am Coll Cardiol 37: 554
Mahanonda N, Bhuripanyo K, Kangkagate C et al. (1995) Randomized double-blind placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table results. Am Hear J. 130: 1250–1253
Maisel WH, Stevenson WG (2002) Syncope — Getting to the heart of the matter. N Engl J Med 347: 931–933
Mark AL, Kioschos JM, Abboud FM et al. (1973) Abnormal vascular responses to exercise in patients with aortic stenosis. J Clin Invest 52: 1138–1146
Martin TP, Hanusa BH, Kapoor WN (1997) Risk stratification of patients with syncope. Ann Emerg Med 29: 459–466
Menozzi C, Brignole M, Garcia-Civera R et al. (2002) Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 105: 2741–2745
Mercader MA, Varghese PJ, Potolicchio SJ (2002) New insights into the mechanism of neurally mediated syncope. Heart 88: 217–221
Moya A, Brignole M, Menozzi C et al. (2001) Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 104: 1261–1267
Oribe E, Caro S, Perera R et al. (1997) Syncope: the diagnostic value of head-up tilt testing. PACE 20: 874–879
Perez-Lugones A, Schweikert R, Pavia S et al. (2001) Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12: 935–938
Quan KJ, Carlson MD, Thames MD (1997) Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. PACE 20: 764–774
Raviele A, Brignole M, Sutton R et al. (1999) Effect of etilefrine in preventing syncopal recurrance in patients with vasovagal syncope. Circulation 99: 1452–1457
Reybrouck T, Heidbuchel H, Werf F van de, Ector H (2002) Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 25: 1441–1446
Saadijan AY, Levy S, Franceschi F et al. (2002) Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 106: 569–574
Samniah M, Sakaguchi S, Lurie KG et al. (2001) Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 88: 80–83
Santini M, Colivicchi F (2002) In-hospital management of syncope: the european perspective. Eur Heart J 23: 767–768
Sarasin FP, Louis-Simonet M, Carabello D et al. (2002a) Prevalence of orthostatic hypotension among patients presenting with syncope in the ED. Am J Emerg Med 20: 497–501
Sarasin FP, Junod AF, Carabello D et al. (2002b) Role of echocardiography in the evaluation of syncope: a prospective study. Heart 88: 363–367
Sheldon RS, Raj SR, Rose S, Connolly SJ (2001) Beta-blockers in syncope: the jury is still out. J Am Coll Cardiol 38: 2135
Sheldon RS, Rose S, Ritchie D et al. (2002) Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 40: 142–148
Sneddon JF, Scalia G, Ward DE et al. (1994) Exercise induced vasodepressor syncope. Br. Heart J 71: 554–557
Soteriades ES, Evans JC, Larson MG et al. (2002) Incidence and prognosis of syncope. N Engl J Med 347: 878–885
Sra JS, Jazayeri MR, Avitall B et al. (1993) Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 328: 1085–1090
Sutton R, Brignole M, Menozzi C et al. (2000) Dual-chamber pacing in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomised study (VASIS trial). Circulation 102: P294
Task Force on Syncope (2004) Guidelines on management (diagnosis and treatment) of syncope. Update 2004. Europace 6: 467–537
Thomson HL, Lele SS, Atherton JJ et al. (1995) Abnormal forearm vascular responses during dynamic leg exercised in patients with vasovagal syncope. Circulation 92: 2204–2209
Venture R, Maas R, Zeidler D et al. (2002) A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 25: 816–821
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
von Scheidt, W. (2006). Synkope. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_9
Download citation
DOI: https://doi.org/10.1007/3-540-29425-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23742-6
Online ISBN: 978-3-540-29425-2
eBook Packages: Medicine (German Language)